vimarsana.com

Latest Breaking News On - Immunoadoptive cell therapy private - Page 1 : vimarsana.com

Power Grid: Power Grid Corp Pledges 42l To Equip Cancer Hosps | Varanasi News

Varanasi: A memorandum of understanding (MoU) was signed by the Power Grid Corporation of India Limited and the Mahamana Pandit Madan Mohan Malviya Ca.

Madho singhUttar pradeshSatyajit pradhanArun kumar raiTata memorial centreTata memorial centerMahamana pandit madan mohan malviya cancer centreDepartment of atomic energyImmunoadoptive cell therapy privatePower grid corporation of indiaPower grid corporationMahamana pandit madan mohan malaviya cancer centreIndia limitedHomi bhabha cancer hospitalAtomic energyPandit madan mohan malaviya cancer centre

Laurus Labs buys additional stake in ImmunoACT for Rs 80 Cr

To hold 33.86% stake post-completion of the transaction

United statesAmerican society of hematologyImmunoadoptive cell therapy privateLaurus labHyderabad based laurus labsImmunoadoptive cell therapy private limitedLaurus labsNavi mumbaiTata memorialAmerican society

Laurus Labs share price rises 3% on further investments in Cell and Gene therapy company

Company in the quarter ended March 2023 reported 55.3 percent fall in its Q4FY23 net profit at Rs 102.98 crore against Rs 230.50 crore in March 2022.

United statesSatyanarayana chavaLaurus labImmunoadoptive cell therapy privateAmerican society of hematologyImmunoadoptive cell therapy private limitedLaurus labsTata memorialAmerican societyGene therapyChief executive officerLaurus labs share price

Laurus Labs further invests in gene therapy tech, increases its stake in lmmunoACT to 33 86%

ImmunoACT has portfolio of Chimeric Antigen Receptor T cells (CAR-T cells) therapy assets under various development stages for the treatment of multiple auto immune diseases and oncology indications.

United statesAndhra pradeshSatyanarayana chavaNeha myneniRahul purwarImmunoadoptive cell therapy privateLaurus labIndian council of medical researchAmerican society of hematologyLaurus labsImmunoadoptive cell therapy private limitedGene therapyNavi mumbaiTata memorialAmerican societyIndian patients

Laurus Labs invests in ImmunoACT to acquire additional stake of 7 24%

Post the completion of the deal, Laurus Labs’ stake in ImmunoACT will increase to 33.86% on fully diluted basis.

United statesSatyanarayana chavaRahul purwarLaurus labImmunoadoptive cell therapy privateAmerican society of hematologyLaurus labsImmunoadoptive cell therapy private limitedNavi mumbaiTata memorialAmerican societyGene therapyChief executiveIndian patients

vimarsana © 2020. All Rights Reserved.